29 June

Plenary meeting room (N201) 

The Management of the HIV Patient: Where have we been, where are we now, where do we need to go?

In a relatively short period (< 35 years) the HIV infection evolved from a disease with an almost 100% mortality after 5-10 years of the infection to a disease with a potential life expectancy similar to the general population and with a reasonably good quality of life. Along this way, the milestones had been: 1) the introduction of the first antiretroviral agent (zidovudine) in 1986; 2) the introduction of highly active antiretroviral therapy (ART) about ten years later in 1986; 3) the introduction of the integrase strand transfer inhibitors (INSTI) starting in 2008; 4) the widespread acceptance of the concept that all HIV-infected persons deserve ART irrespective of the CD4+cell count. Still there is room to improve the future ART, prevention, sexual education and the possibility of a remission.

Speaker: José Gatell, Senior Global Medical Director, ViiV Healthcare; Professor of Medicine, University of Barcelona


ViiV Healthcare

29 June

Plenary meeting room (N201)

One Step Further – Can Asia Become Free from HIV?

Gilead Sciences will re-examine HIV medicine with an Asian perspective. Join with regional Asia medical experts  and engage in a down-to-earth dialogue on current HIV statistics, new  treatment and prevention research data, and share in valuable experiences from neighboring countries. Please join Gilead Sciences for this discussion on steps needed to make Asia “HIV-free”.

17:00–17:05 Introduction: How is Asia Fighting Against HIV Epidemic
17:05–17:47 Exploring the reality of the Asian HIV epidemic
17:47–17:57 Q&A from audience
17:57–18:00 Closing: Call to action: what is the Asia Game Plan to End the Epidemic 


 Gilead Sciences

30 June

Plenary meeting room (N201) 

The 4th 90: Quality of Life
Ageing with HIV in Asia and the Pacific

The Australasian Society of HIV, Viral Hepatitis and Sexual Health Medicine (ASHM) will discuss the the clinical, psychosocial and service delivery needs of ageing HIV populations. The session aims to equip attendees with the knowledge and skills to ensure that best practice care and treatment is provided. Clinicians from across the region will share their experiences of providing specialist care, optimal models of service delivery and engaging with community organisations.

Learning objectives

  • Understanding co-morbidities in older PLHIV
  • Linking with community organisations to support ageing HIV populations
  • Functional ageing vs chronological ageing for PLHIV
  • Different models of care and service delivery for ageing HIV populations
  • What different countries in the region are doing to support their ageing HIV populations 


  • Scott McGill, Acting CEO, ASHM, Australia
  • Dr Gary Lee, Holdsworth House, Australia
  • Dr Dariusz Olszyna, National University Hospital, Singapore
  • Dr Grace Lui, Hong Kong Society for HIV Medicine
  • Ivy Hui, Program Manager, The Society for AIDS Care, Hong Kong
  • Dr Evy Yunihastuti, Department of Internal Medicine University of Indonesia


ASHM -  Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine